Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Sihuan Pharmaceutical Holdings Group ( (HK:0460) ) is now available.
Sihuan Pharmaceutical Holdings Group Ltd. announced the composition of its board of directors and their roles within the company, effective from September 1, 2025. This announcement highlights the leadership structure and governance of the company, which could impact its strategic direction and reassure stakeholders about its management stability.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd. is a company incorporated in Bermuda, focusing on the pharmaceutical industry. It is involved in the development and manufacturing of pharmaceutical products, with a market focus on healthcare solutions.
Average Trading Volume: 114,359,493
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.44B
For detailed information about 0460 stock, go to TipRanks’ Stock Analysis page.